In these studies, multiple tumor tissues from patients and cancer cell lines have been tested for CBS expression, and revealed increasing mRNA and/or protein levels compared to adjacent normal tissue or non-malignant equivalent cells. This evidence concerns the gene CBS and neoplasm.